EFFECT OF COMPLEMENTARY DRUG REGIMEN ON CORONARY ARTERIOSCLEROSIS

这些研究是方案#20-1的延续，除了 添加普罗布考作为药物之一。 因为我们现在可以正常化LDL 杂合子型家族性高胆固醇血症患者的胆固醇水平 使用联合药物方案，我们正在测试方案的能力， 通过计算机血管造影术测量动脉粥样硬化斑块的收缩。 研究了治疗对患者血浆游离钙水平的影响。 脂肪酸

These studies are a continuation of protocol #20-1, except for the addition of probucol as one of the drugs. Since we can now normalize LDL cholesterol in patients with heterozygous familial hypercholesterolemia using a combined drug regimen, we are testing the regimen's ability to shrink atherosclerotic plaques as measured by computerized angiography. Patients are studied in the effect of treatment on levels of plasma free fatty acid.